These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8327030)

  • 1. [Erythropoietin and recombinant erythropoietin: new effects, new indications].
    Souweine B; Deteix P
    Nephrologie; 1993; 14(2):71-4. PubMed ID: 8327030
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erythropoietin treatment: concept and controversy].
    Sans Mateu T
    Sangre (Barc); 1998 Aug; 43(4):327-30. PubMed ID: 9790000
    [No Abstract]   [Full Text] [Related]  

  • 3. The neuroprotective role of erythropoietin in the management of acute ischaemic stroke: from bench to bedside.
    Ntaios G; Savopoulos C; Chatzinikolaou A; Hatzitolios AI
    Acta Neurol Scand; 2008 Dec; 118(6):362-6. PubMed ID: 18513348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?].
    Pérez-García R; Rodríguez-Benítez P; Villaverde MT; Valderrábano F
    Nefrologia; 2001; 21(6):606-7. PubMed ID: 11881433
    [No Abstract]   [Full Text] [Related]  

  • 5. [Erythropoietin resistance].
    Branger B
    Nephrologie; 2002; 23(1):3-5. PubMed ID: 11887576
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythropoietin: a new paradigm.
    Spivak JL
    J Lab Clin Med; 1990 Jan; 115(1):10-1. PubMed ID: 2405079
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice.
    Yoshimi M; Maeyama T; Yamada M; Hamada N; Fukumoto J; Kawaguchi T; Kuwano K; Nakanishi Y
    Respirology; 2008 Sep; 13(5):639-45. PubMed ID: 18713087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of recombinant human erythropoietin therapy on red cell expansion during autologous blood donation.
    Goodnough LT; Marcus RE
    Contemp Orthop; 1994 Dec; 29(6):430-4. PubMed ID: 10150254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin improves enzyme activity in erythrocytes of predialysis uremics.
    Pietrzak I; Baczyk K; Kubiak W
    Miner Electrolyte Metab; 1996; 22(1-3):102-5. PubMed ID: 8676797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant human erythropoietin and interleukin-3 on erythropoietic recovery from acute anemia.
    Rosen BS; Levine EA; Egrie JC; Sehgal LR; Greenberg R; Rosen AL; Levine HD; Gould SA
    Exp Hematol; 1993 Oct; 21(11):1487-91. PubMed ID: 8405228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant erythropoietin: 10 years of clinical experience.
    Valderrábano F
    Nephrol Dial Transplant; 1997; 12 Suppl 1():2-9. PubMed ID: 9075222
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy with recombinant erythropoietin in paroxysmal nocturnal haemoglobinuria.
    Balleari E; Mareni C; Marmont AM; Ghio R
    Br J Haematol; 1996 Aug; 94(2):424. PubMed ID: 8759911
    [No Abstract]   [Full Text] [Related]  

  • 14. Durable response to recombinant human erythropoietin in a patient with myelodysplastic syndrome.
    Pedrotti C
    Haematologica; 1996; 81(6):591. PubMed ID: 9009449
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).
    Chen G; Shi JX; Hang CH; Xie W; Liu J; Liu X
    Neurosci Lett; 2007 Oct; 425(3):177-82. PubMed ID: 17825990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin in myelodysplastic syndromes: durable response in a young patient.
    Aloe Spiriti MA; Latagliata R; Petti MC
    Haematologica; 1996; 81(4):381-2. PubMed ID: 8870388
    [No Abstract]   [Full Text] [Related]  

  • 17. [Human recombinant erythropoietin in the treatment of the anemia of multiple myeloma].
    Valladares Ayerbes MJ; Valenzuela Claros JC; Reina Zoilo JJ; Ruiz Borrego M; Moreno Nogueira JA
    An Med Interna; 1997 Nov; 14(11):593-4. PubMed ID: 9445590
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of erythropoietin in HIV myelodysplasias. Preliminary study].
    Fruttaldo L; Gatti G; Deambrogio V; Mongiò F; Schettino G; Cavagnolo G
    Minerva Med; 1993 Mar; 84(3):103-5. PubMed ID: 8492960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant erythropoietin in anemia of prematurity: five years later.
    Shannon K
    Pediatrics; 1993 Oct; 92(4):614-7. PubMed ID: 8414840
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant human erythropoietin treatment of anemic cancer patients.
    Henry DH
    Cancer Pract; 1996; 4(4):180-4. PubMed ID: 8900758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.